Your browser doesn't support javascript.
loading
An intelligent DNA nanorobot for detection of MiRNAs cancer biomarkers using molecular programming to fabricate a logic-responsive hybrid nanostructure.
Mirzaiebadizi, Amin; Ravan, Hadi; Dabiri, Shahriar; Mohammadi, Pourya; Shahba, Arezoo; Ziasistani, Mahsa; Khatami, Mehrdad.
Afiliação
  • Mirzaiebadizi A; Department of Biology, Faculty of Sciences, Shahid Bahonar University of Kerman, Kerman, Iran.
  • Ravan H; Institute of Biochemistry and Molecular Biology II, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
  • Dabiri S; Department of Biology, Faculty of Sciences, Shahid Bahonar University of Kerman, Kerman, Iran. ravan@uk.ac.ir.
  • Mohammadi P; Department of Pathology and Stem Cell Research Center, Kerman University of Medical Sciences, Kerman, Iran. sh_dabiri@kmu.ac.ir.
  • Shahba A; Department of Chemistry, Shahid Bahonar University of Kerman, Kerman, Iran.
  • Ziasistani M; Department of Biology, Faculty of Sciences, Shahid Bahonar University of Kerman, Kerman, Iran.
  • Khatami M; Department of Pathology and Stem Cell Research Center, Kerman University of Medical Sciences, Kerman, Iran.
Bioprocess Biosyst Eng ; 45(11): 1781-1797, 2022 Nov.
Article em En | MEDLINE | ID: mdl-36125526
ABSTRACT
Herein, we designed a DNA framework-based intelligent nanorobot using toehold-mediated strand displacement reaction-based molecular programming and logic gate operation for the selective and synchronous detection of miR21 and miR125b, which are known as significant cancer biomarkers. Moreover, to investigate the applicability of our design, DNA nanorobots were implemented as capping agents onto the pores of MSNs. These agents can develop a logic-responsive hybrid nanostructure capable of specific drug release in the presence of both targets. The prosperous synthesis steps were verified by FTIR, XRD, BET, UV-visible, FESEM-EDX mapping, and HRTEM analyses. Finally, the proper release of the drug in the presence of both target microRNAs was studied. This Hybrid DNA Nanostructure was designed with the possibility to respond to any target oligonucleotides with 22 nucleotides length.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: MicroRNAs / Nanoestruturas / Neoplasias Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Bioprocess Biosyst Eng Assunto da revista: BIOTECNOLOGIA / ENGENHARIA BIOMEDICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irã

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: MicroRNAs / Nanoestruturas / Neoplasias Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Bioprocess Biosyst Eng Assunto da revista: BIOTECNOLOGIA / ENGENHARIA BIOMEDICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irã